Solventum Price to Book Ratio 2023-2025 | SOLV
Historical price to book ratio values for Solventum (SOLV) over the last 10 years. The current price to book ratio for Solventum as of July 15, 2025 is 3.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Solventum Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-07-15 | 73.68 | 3.91 | |
2025-03-31 | 76.04 | $18.85 | 4.03 |
2024-12-31 | 66.06 | $17.13 | 3.86 |
2024-09-30 | 69.72 | $18.48 | 3.77 |
2024-06-30 | 52.88 | $16.57 | 3.19 |
2024-03-31 | 69.55 | $22.30 | 3.12 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.815B | $8.254B |
Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $141.524B | 26.54 |
CVS Health (CVS) | United States | $81.417B | 10.12 |
Elevance Health (ELV) | United States | $76.834B | 9.91 |
Cencora (COR) | United States | $57.577B | 20.03 |
DiDi Global (DIDIY) | China | $25.180B | 26.75 |
Natera (NTRA) | United States | $21.599B | 0.00 |
Labcorp Holdings (LH) | United States | $20.908B | 16.96 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.318B | 0.00 |
CochLear (CHEOY) | Australia | $13.009B | 0.00 |
ICON (ICLR) | Ireland | $12.075B | 11.23 |
Revvity (RVTY) | United States | $11.607B | 19.97 |
Viatris (VTRS) | United States | $10.727B | 3.69 |
Medpace Holdings (MEDP) | United States | $9.208B | 24.45 |
Avantor (AVTR) | United States | $9.009B | 13.09 |
Sonic Healthcare (SKHHY) | Australia | $8.842B | 0.00 |
HealthEquity (HQY) | United States | $8.418B | 36.87 |
Charles River Laboratories (CRL) | United States | $7.762B | 15.21 |
Caris Life Sciences,�Inc (CAI) | United States | $7.052B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.840B | 28.50 |
BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
Sotera Health (SHC) | United States | $3.296B | 18.73 |
Surgery Partners (SGRY) | United States | $2.880B | 37.45 |
Alignment Healthcare (ALHC) | United States | $2.651B | 0.00 |
Concentras Parent (CON) | United States | $2.593B | 14.98 |
Organon (OGN) | United States | $2.550B | 2.71 |
GeneDx Holdings (WGS) | United States | $2.351B | 90.54 |
Ardent Health (ARDT) | United States | $2.073B | 8.84 |
Progyny (PGNY) | United States | $2.012B | 44.28 |
PACS (PACS) | United States | $1.966B | 0.00 |
Premier (PINC) | United States | $1.750B | 13.28 |
GoodRx Holdings (GDRX) | United States | $1.725B | 34.50 |
Teladoc Health (TDOC) | United States | $1.451B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.316B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.131B | 8.60 |
CareDx (CDNA) | United States | $1.115B | 17.41 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.931B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.791B | 7.41 |
Nutex Health (NUTX) | United States | $0.645B | 9.76 |
Embecta (EMBC) | United States | $0.606B | 4.08 |
InnovAge Holding (INNV) | United States | $0.582B | 0.00 |
SBC Medicals (SBC) | United States | $0.518B | 0.00 |
LifeMD (LFMD) | United States | $0.514B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.487B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.473B | 10.65 |
Omada Health (OMDA) | $0.452B | 0.00 | |
So-Young (SY) | China | $0.430B | 0.00 |
Enhabit (EHAB) | United States | $0.359B | 29.50 |
COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.331B | 0.00 |
Oncology Institute (TOI) | United States | $0.286B | 0.00 |
Beauty Health (SKIN) | United States | $0.236B | 0.00 |
DocGo (DCGO) | United States | $0.149B | 24.33 |
Pheton Holdings (PTHL) | China | $0.142B | 0.00 |
Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
KindlyMD (NAKA) | United States | $0.073B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.056B | 0.00 |
ModivCare (MODV) | United States | $0.047B | 0.00 |
Biodesix (BDSX) | United States | $0.046B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |